The Delta variant is causing a massive surge in COVID-19 infections across the globe. Everyone, no matter where they live, should have access to COVID-19 vaccines as well as public health tools like PPE, diagnostic tests, oxygen and other therapies. In a recently published op-ed, Executive Director of the Global Fund Peter Sands writes, “beating COVID-19 will take a sustained and comprehensive response, combining vaccines, tests, treatments and PPE.”
With U.S. and other donors support, the Global Fund’s COVID-19 Response Mechanism is strengthening national COVID-19 responses while protecting life-saving AIDS, TB and malaria programs. Through grants, the Global Fund is supplying essential health products like diagnostic tests, PPE and medical oxygen.
A Rapid and Effective Response
As of September 14, the Global Fund has awarded nearly $3.65 billion in COVID-19 funding in three major areas of impact.
76.5% Reinforcing national COVID-19 response
10% Mitigating COVID-19 impact on HIV, TB and malaria programs
13.5% Making urgent improvements to health and community systems to help fight COVID-19
Funding by Health Products (September 2021)
A Far Reaching Global Response
The Global Fund is moving rapidly to deploy COVID-19 response funds in over 105 countries and 14 multi-country programs around the world.
Broad Donor Support
Over 9 countries have contributed to the Global Fund’s COVID-19 Response Mechanism. As of August, the Global Fund has awarded 60% of contributions.
How Countries Are Using COVID-19 Support from the Global Fund
HIV and TB Infrastructure Support Nigeria’s COVID-19 Response:
Investments by the Global Fund’s COVID-19 Response Mechanism nearly quadrupled Nigeria’s laboratory sites and expanded oxygen capacity. Dr. Gambo Aliyu, the director-general of the National Agency for the Control of AIDS, highlights a key lesson from Nigeria’s COVID-19 response, stating, “above all, what we have learned that works is the integration of services. Community health workers went door-to-door, offering COVID-19, HIV and TB services.” Read More
Uganda’s rapid COVID-19 response
Since March 2021, The Global Fund disbursed over $51 million alongside over $10 million of grant saving in Uganda to respond to COVID-19 “to rapidly adapt existing HIV, TB and malaria programs, purchase personal protective equipment (PPE) for front-line health workers, diagnostics and medical supplies and to deploy prevention campaigns.” As of July 2021, the Global Fund has delivered 2.5 million diagnostic tests and nearly 600 thousand PCR tests to Uganda. Read More
Adapting HIV services during Eswatini’s lockdown
During recent COVID-19 lockdowns in Eswatini, the Global Fund’s COVID-19 Response Mechanism ensured that adolescent girls and young women at risk of HIV infection continued to access HIV prevention programs. Through grants, the Global Fund helped partners like CANGO adapt their risk reduction programs online to ensure that young women and adolescent girls continued to receive essential HIV prevention support remotely. Read More
Ambulances and emergency supplies donated to Malawi during Delta variant surge
Malawi faces a surge of COVID-19 infections, fueled by the highly contagious Delta variant. In July 2021, the Global Fund and Gavi donated ambulances, motorcycles and medical equipment to Malawi’s government in order to bolster the national COVID-19 response and mitigate disruption of HIV, TB and malaria programs. Read More
Oxygen for India
Since May 2021, the Global Fund has approved $75 million for emergency oxygen concentrators and Pressure Swing Adsorption oxygen plants as India experienced a surge in COVID-19 cases that overwhelmed health systems. Read More
COVID-19 is causing a devastating oxygen crisis in low and middle income countries. Read More